Position in CHRS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$21,000
-$4,350 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 145 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Providence Wealth Advisors, LLC holds $74,250 across 2 Biotechnology names. CHRS ranks #2 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALDX |
Aldeyra Therapeutics, Inc.
|
25,000 | $53,250 | |
| 2 | CHRS |
Coherus Oncology, Inc.
This page
|
15,000 | $21,000 |
All Filings in CHRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,000 | 15,000 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $25,350 | 15,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $21,300 | 15,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $24,600 | 15,000 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $10,965 | 15,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,087 | 12,500 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $17,250 | 12,500 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $10,400 | 10,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||